400
Participants
Start Date
February 28, 2001
Abacavir sulfate, Lamivudine and Zidovudine
Efavirenz
Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ, New York
SUNY / Health Sciences Ctr at Brooklyn, Brooklyn
Georgetown Univ Med Ctr, Washington D.C.
Infectious Disease Physicians Inc, Annandale
Infectious Disease Consultants, Fairfax
East Carolina Univ School of Medicine, Greenville
ID Consultants, Charlotte
Infectious Disease Specialists of Atlanta, Decatur
Infectious Disease Consultants, Altamonte Springs
Univ of Miami / Jackson Memorial Hosp, Miami
SBMA Research, Miami Beach
North Broward Hosp District / HIV Clinical Research, Fort Lauderdale
Univ of Tennessee Med Ctr at Knoxville, Knoxville
CRC of Mississippi, Jackson
University of Louisville / ID Division, Louisville
Summa Health System, Akron
Dr Paul Benson, Berkley
Regions Hosp / HIV/AIDS Program, Saint Paul
Hennepin County Med Ctr, Minneapolis
Cook County Gen Hosp / Division of Infect Diseases, Chicago
Northstar Med Clinic, Chicago
HIV Outpatient Clinics / LA State Univ Med Ctr, New Orleans
Health for Life Clinic, Little Rock
Univ of Oklahoma Infectious Disease Institute, Oklahoma City
Associates in Med and Mental Health, Tulsa
AIDS Outreach Center, Fort Worth
Metroplex Infectious Disease, Fort Worth
Tarrant County Infectious Diseases Associates, Fort Worth
Therapeutic Concepts, Houston
Diversified Med Practices, PA, Houston
Infectious Diseases Associates of Houston, Houston
Texas Tech Health Sciences Ctr, El Paso
Beacon Clinic / Boulder Community Hosp, Boulder
Phoenix Body Positive, Phoenix
Wellness Ctr / Las Vegas, Las Vegas
Orange County Ctr for Special Immunology, Fountain Valley
Pacific Horizons Med Group, San Francisco
Swedish Med Ctr, Seattle
Dupont Circle Physicians Group, Washington D.C.
Boston Med Ctr, Boston
Hackensack University Medical Center, Hackensack
NJCRI, Newark
Lead Sponsor
GlaxoSmithKline
INDUSTRY